Health and Healthcare

Abbott Laboratories : ABT

All Abbott Laboratories Articles

311 Articles

Trey Thoelcke | Aug 21, 2012 at 10:56 AM EDT

Medical Device Recalls at Eight-Month High

The quarterly ExpertRECALL Index released today indicates that more than 123 million medical device units were recalled during the second…

Douglas A. McIntyre | Aug 20, 2012 at 6:35 AM EDT

Companies Paying Their CEOs More Than the Taxman

The press recently had a field day with a report from the “Institute for Policy Studies” about executive pay. The…

247sam | Jul 27, 2012 at 11:23 AM EDT

Amarin Shares Fall Despite Regulatory OK

Usually, shares of drug makers soar following the announcement that the Foood and Drug Administration approved a drug. Amarin Corp.…

Paul Ausick | Jul 23, 2012 at 2:36 PM EDT

S&P 500 Companies Beating on Earnings, Missing on Revenues

At the end of two weeks of non-stop second quarter earnings reports, S&P Capital IQ expects a decline of -0.71%…

Paul Ausick | Jul 18, 2012 at 4:06 PM EDT

24/7 Wall St. Closing Bell — July 18, 2012: Markets Rise on Lack of Bad News

The three major US stock indexes opened modestly lower this morning as there was little news out of Europe and…

Paul Ausick | Jul 18, 2012 at 10:56 AM EDT

Top 10 U.S. Drugs for 2012 First Quarter

Online drug research firm drugs.com today released its list of the top 100 selling drugs in the United States for…

Paul Ausick | Jul 18, 2012 at 8:34 AM EDT

Abbott Labs Stung by Foreign Exchange Rate

Abbott Laboratories (NYSE: ABT) reported second-quarter results this morning that beat the consensus estimate for earnings per share (EPS), but…

Paul Ausick | Jul 17, 2012 at 4:03 PM EDT

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

The three major US stock indexes opened higher this morning in advance of Fed Chairman Ben Bernanke’s semi-annual report to…

Jon C. Ogg | Jul 17, 2012 at 2:17 PM EDT

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Wednesday is going to mark yet another important day for the early wave of key earnings for this earnings season. …

Jon C. Ogg | Apr 4, 2012 at 1:28 PM EDT

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment…

Paul Ausick | Mar 8, 2012 at 1:49 PM EST

Abbott Labs Posts New High on FDA Approval (ABT)

Health care products maker Abbott Laboratories (NYSE: ABT) received US Food and Drug Administration approval to market its new glucose…

Jon C. Ogg | Jan 25, 2012 at 7:58 AM EST

Abbott Earnings Beat As Sales Growth Lags (ABT)

Abbott Laboratories (NYSE: ABT) may be in the midst of a long-term restructuring, but the company turned in earnings growth…

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

Douglas A. McIntyre | Oct 20, 2011 at 4:15 AM EDT

America’s Most Overpaid CEOs

It’s that time of year again, when proxies are released and many business publications run lists of the highest paid…

Paul Ausick | Oct 19, 2011 at 4:20 PM EDT

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

Stocks opened down this morning following the earnings report Apple Inc. (NASDAQ: AAPL) after markets closed yesterday. Moody’s downgrade of Spain’s…

1 … 12 13 14 15 16 … 21

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Medical Device Recalls at Eight-Month High

Companies Paying Their CEOs More Than the Taxman

Amarin Shares Fall Despite Regulatory OK

S&P 500 Companies Beating on Earnings, Missing on Revenues

24/7 Wall St. Closing Bell — July 18, 2012: Markets Rise on Lack of Bad News

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Abbott Labs Posts New High on FDA Approval (ABT)

Abbott Earnings Beat As Sales Growth Lags (ABT)

Short Sellers Help Push Dendreon Higher

America’s Most Overpaid CEOs

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Medical Device Recalls at Eight-Month High

Companies Paying Their CEOs More Than the Taxman

Amarin Shares Fall Despite Regulatory OK

S&P 500 Companies Beating on Earnings, Missing on Revenues

24/7 Wall St. Closing Bell — July 18, 2012: Markets Rise on Lack of Bad News

Top 10 U.S. Drugs for 2012 First Quarter

Abbott Labs Stung by Foreign Exchange Rate

24/7 Wall St. Closing Bell — July 17, 2012: Markets Higher After Bernanke Speaks

10 Key Earnings Previews For Wednesday (ABT, AXP, BAC, DAL, EBAY, HON, IBM, QCOM, USB, YUM)

Abbott’s Hep-C Pressures All Hep-C Rivals (ABT, RIGL, GILD, VRTX, IDIX)

Abbott Labs Posts New High on FDA Approval (ABT)

Abbott Earnings Beat As Sales Growth Lags (ABT)

Short Sellers Help Push Dendreon Higher

America’s Most Overpaid CEOs

24/7 Wall St. Closing Bell (AAPL, WMT, WFM, MS, BAC, INTC, WMB, HGSI, ABT, OXGN, PWAV, AEM)

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

This High-Yield ETF Combines Bond Investing With Emerging Market Currencies

SoFi Stock Could Jump 26% as Market Overreacts to One Soft Segment

Featured Reads

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026